Why the DEA’s latest telehealth initiative could be a lifesaver
What are the news: Physicians can continue to prescribe controlled substances based on telehealth patient visits after the Drug Enforcement Administration (DEA) extended this regulatory flexibility through December 31, 2024. The AMA is grateful that the DEA recognizes that patients treated with these medications, including medications to treat opioid use disorder, often have difficulty obtaining …